7 research outputs found
Primum Non Nocere in interventional oncology for liver cancer: How to reduce the risk for complications?
: Interventional oncology represents a relatively new clinical discipline based upon minimally
invasive therapies applicable to almost every human organ and disease. Over the last several decades,
rapidly evolving research developments have introduced a newer generation of treatment devices,
reagents, and image-guidance systems to expand the armamentarium of interventional oncology
across a wide spectrum of disease sites, offering potential cure, control, or palliative care for many
types of cancer patients. Due to the widespread use of locoregional procedures, a comprehensive
review of the methodologic and technical considerations to optimize patient selection with the
aim of performing a safe procedure is mandatory. This article summarizes the expert discussion
and report from the Mediterranean Interventional Oncology Live Congress (MIOLive 2020) held in
Rome, Italy, integrating evidence-reported literature and experience-based perceptions as a means
for providing guidance on prudent ways to reduce complications. The aim of the paper is to
provide an updated guiding tool not only to residents and fellows but also to colleagues approaching
locoregional treatments
Primum Non Nocere in interventional oncology for liver cancer: How to reduce the risk for complications?
: Interventional oncology represents a relatively new clinical discipline based upon minimally
invasive therapies applicable to almost every human organ and disease. Over the last several decades,
rapidly evolving research developments have introduced a newer generation of treatment devices,
reagents, and image-guidance systems to expand the armamentarium of interventional oncology
across a wide spectrum of disease sites, offering potential cure, control, or palliative care for many
types of cancer patients. Due to the widespread use of locoregional procedures, a comprehensive
review of the methodologic and technical considerations to optimize patient selection with the
aim of performing a safe procedure is mandatory. This article summarizes the expert discussion
and report from the Mediterranean Interventional Oncology Live Congress (MIOLive 2020) held in
Rome, Italy, integrating evidence-reported literature and experience-based perceptions as a means
for providing guidance on prudent ways to reduce complications. The aim of the paper is to
provide an updated guiding tool not only to residents and fellows but also to colleagues approaching
locoregional treatments
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey.
BACKGROUND AND AIMS: Aim of this study was to compare liver resection and radiofrequency ablation in patients with single hepatocellular carcinoma <= 3 cm and compensated cirrhosis.
METHODS: The study involved 544 Child-Pugh A cirrhotic patients (246 in resection group and 298 in radiofrequency group) observed in 15 Italian Centers. Overall survival and tumor recurrence rates were analyzed using Kaplan Meier method before and after propensity score matching. Cox regression models were used to identify factors associated with overall survival and tumor recurrence.
RESULTS: Two cases of perioperative mortality were observed in resection group and the rate of major complications was 4.5% in resection group and 2.0% in radiofrequency group (p=0.101). Four-year overall survival rates were 74.4% in resection group and 66.2% in radiofrequency group (p=0.353). Four-year cumulative HCC recurrence rates were 56% in resection group and 57.1% in radiofrequency group (p=0.765). Local tumor progression was detected in 20.5% of ablated patients and in one resected patient (p<0.001). After propensity score matching, both survival and tumor recurrence were still not significantly different although a trend towards lower recurrence was observed in RES patients. Older age and higher alpha-fetoprotein levels were independent predictors of poor overall survival while older age and higher alanine-aminotransferase levels resulted to be independent factors associated with higher recurrence rate.
CONCLUSIONS: In spite of a higher rate of local tumor progression, radiofrequency ablation can provide results comparable to liver resection in the treatment of single hepatocellular carcinoma <=3 cm occurring in compensated cirrhosis
Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features
OBJECTIVE: Incidence of intrahepatic mass-forming cholangiocarcinoma (IMCC) is increasing worldwide, especially in patients with chronic liver disease. The small and the histologically well-differentiated IMCCs in chronic liver disease could be arterially hypervascular lesions with/without washout on computed tomography (CT) and magnetic resonance imaging (MRI), mimicking typical hepatocellular carcinoma (HCC). The aim of this work is to evaluate contrast enhancement (CE) patterns of IMCCs at quadri-phasic multidetector CT (4-MDCT) and MRI, using imaging-clinicopathologic correlation.
PATIENTS AND METHODS: The 4-MDCT and MR images of 56 histologically confirmed IMCCs were retrospectively evaluated for tumor morphology and enhancement features. Enhancement pattern was defined according to the behavior of the nodule in arterial (AP), portal venous (PVP) and equilibrium phases (EP), and dynamic pattern was described according to enhancement progression throughout the different phases. Arterial and dynamic enhancement patterns were correlated with chronic liver disease, tumor size and histological differentiation.
RESULTS: Most of the nodules were peripherally hyperenhancing (50%) on AP, and partially hyperenhancing on PVP (67.9%) and EP (80.3%). Forty-six (82.1%) IMCCs showed progressive CE, 7 (12.5%) stable CE and 3 (5.4%) wash-out. In normal liver there were 34 nodules with progressive and 3 with stable CE, whereas in chronic liver disease there were 12 IMCCs with progressive, 4 with stable and 3 with washout pattern (p = 0.01); IMCCs with progressive CE were more differentiated than IMCCs with stable CE and wash-out (p = 0.02).
CONCLUSIONS: The most prevalent enhancement pattern of IMCCs was arterial rim enhancement followed by progressive and concentric filling. The stable and the washout patterns were more frequent in poorly differentiated IMCCs. Contrast washout was observed only in IMCCs emerging in chronic liver disease with a risk of misdiagnosis with HCC
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma
Our aim was to evaluate the effectiveness of the single-step combined therapy with radiofrequency ablation and drug-eluting beads transarterial chemoembolization in single hepatocellular carcinoma (HCC) larger than 3cm. Secondary aim was to compare the results with those obtained in a matched population treated with drug-eluting beads transarterial chemoembolization alone
The Italian Consensus on minimally invasive simultaneous resections for synchronous liver metastasis and primary colorectal cancer: A Delphi methodology
At the time of diagnosis synchronous colorectal cancer, liver metastases (SCRLM) account for 15-25% of patients. If primary tumour and synchronous liver metastases are resectable, good results may be achieved performing surgical treatment incorporated into the chemotherapy regimen. So far, the possibility of simultaneous minimally invasive (MI) surgery for SCRLM has not been extensively investigated. The Italian surgical community has captured the need and undertaken the effort to establish a National Consensus on this topic. Four main areas of interest have been analysed: patients' selection, procedures, techniques, and implementations. To establish consensus, an adapted Delphi method was used through as many reiterative rounds were needed. Systematic literature reviews were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses instructions. The Consensus took place between February 2019 and July 2020. Twenty-six Italian centres participated. Eighteen clinically relevant items were identified. After a total of three Delphi rounds, 30-tree recommendations reached expert consensus establishing the herein presented guidelines. The Italian Consensus on MI surgery for SCRLM indicates possible pathways to optimise the treatment for these patients as consensus papers express a trend that is likely to become shortly a standard procedure for clinical pictures still on debate. As matter of fact, no RCT or relevant case series on simultaneous treatment of SCRLM are available in the literature to suggest guidelines. It remains to be investigated whether the MI technique for the simultaneous treatment of SCRLM maintain the already documented benefit of the two separate surgeries